BACE1 and Alzheimer disease: The diminished activity of BVRA was also observed in other animal models of AD to lead to increased BACE1 phosphorylation, Aβ accumulation, and insulin resistance through downregulation of the insulin receptor (IR) and inhibition of IRS [77].